Clinical Trial Update: Electrocautery Ablation for the Prevention of Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of electrocautery ablation to prevent lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University College, London | Conditions: Lung Cancer Squamous Cell | Phase 2, Phase 3 | Status: TERMINATED